Article Boron Compounds Chemistry In-vitro Studies In-vivo Studies Radiobiology Year 2020

Sunitinib containing carborane pharmacophore with ability to inhibit tyrosine kinases receptors, FLT3, KIT, and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity

Cancers, 2020

Article Boron Compounds Boron Determination Chemistry In-vitro Studies Radiobiology Year 2020

Closo-carboranyl- and Metallacarboranyl[1,2,3]-triazolyl-decorated Lapatinib-scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy

Cells, 2020